140 related articles for article (PubMed ID: 33153318)
1. Opa-Interacting Protein 5 Expression in Human Glioma Tissues Is Essential to the Biological Function of U251 Human Malignant Glioma Cells.
Chen L; Wang R; Gao L; Shi W
Cancer Control; 2020; 27(1):1073274820968914. PubMed ID: 33153318
[TBL] [Abstract][Full Text] [Related]
2. Opa interacting protein 5 promotes metastasis of nasopharyngeal carcinoma cells by promoting EMT via modulation of JAK2/STAT3 signal.
Zheng YQ; Cui YR; Yang S; Wang YP; Qiu YJ; Hu WL
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):613-621. PubMed ID: 30720169
[TBL] [Abstract][Full Text] [Related]
3. Opa interacting protein 5 acts as an oncogene in bladder cancer.
He X; Hou J; Ping J; Wen D; He J
J Cancer Res Clin Oncol; 2017 Nov; 143(11):2221-2233. PubMed ID: 28752236
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of Opa interacting protein 5 increases the progression of liver cancer via BMPR2/JUN/CHEK1/RAC1 dysregulation.
Li Y; Xiao F; Li W; Hu P; Xu R; Li J; Li G; Zhu C
Oncol Rep; 2019 Apr; 41(4):2075-2088. PubMed ID: 30816485
[TBL] [Abstract][Full Text] [Related]
5. HOXA10‑AS: A novel oncogenic long non‑coding RNA in glioma.
Dong CY; Cui J; Li DH; Li Q; Hong XY
Oncol Rep; 2018 Nov; 40(5):2573-2583. PubMed ID: 30132568
[TBL] [Abstract][Full Text] [Related]
6. OIP5 Expression Sensitize Glioblastoma Cells to Lomustine Treatment.
Rodrigues-Junior DM; Biassi TP; Carlin V; Buri MV; Torrecilhas AC; Bortoluci KR; Vettore AL
J Mol Neurosci; 2018 Nov; 66(3):383-389. PubMed ID: 30284228
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of linc-OIP5 inhibits proliferation and migration of glioma cells through down-regulation of YAP-NOTCH signaling pathway.
Hu GW; Wu L; Kuang W; Chen Y; Zhu XG; Guo H; Lang HL
Gene; 2017 Apr; 610():24-31. PubMed ID: 28189759
[TBL] [Abstract][Full Text] [Related]
8. OIP5, a target of miR-15b-5p, regulates hepatocellular carcinoma growth and metastasis through the AKT/mTORC1 and β-catenin signaling pathways.
Li H; Zhang J; Lee MJ; Yu GR; Han X; Kim DG
Oncotarget; 2017 Mar; 8(11):18129-18144. PubMed ID: 28184024
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA OIP5-AS1 targets Wnt-7b to affect glioma progression via modulation of miR-410.
Sun WL; Kang T; Wang YY; Sun JP; Li C; Liu HJ; Yang Y; Jiao BH
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30498093
[TBL] [Abstract][Full Text] [Related]
10. Expression of Opa interacting protein 5 (OIP5) is associated with tumor stage and prognosis of clear cell renal cell carcinoma.
Gong M; Xu Y; Dong W; Guo G; Ni W; Wang Y; Wang Y; An R
Acta Histochem; 2013 Oct; 115(8):810-5. PubMed ID: 23664661
[TBL] [Abstract][Full Text] [Related]
11. Loss of the Opa interacting protein 5 inhibits breast cancer proliferation through miR-139-5p/NOTCH1 pathway.
Li HC; Chen YF; Feng W; Cai H; Mei Y; Jiang YM; Chen T; Xu K; Feng DX
Gene; 2017 Mar; 603():1-8. PubMed ID: 27916718
[TBL] [Abstract][Full Text] [Related]
12. Effects of long non-coding RNA Opa-interacting protein 5 antisense RNA 1 on colon cancer cell resistance to oxaliplatin and its regulation of microRNA-137.
Liang J; Tian XF; Yang W
World J Gastroenterol; 2020 Apr; 26(13):1474-1489. PubMed ID: 32308348
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of PLK1 inhibits invasion and promotes apoptosis in glioma cells through regulating autophagy.
Wu ZY; Wei N
Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2723-2733. PubMed ID: 29771424
[TBL] [Abstract][Full Text] [Related]
14. OIP5 is a highly expressed potential therapeutic target for colorectal and gastric cancers.
Chun HK; Chung KS; Kim HC; Kang JE; Kang MA; Kim JT; Choi EH; Jung KE; Kim MH; Song EY; Kim SY; Won M; Lee HG
BMB Rep; 2010 May; 43(5):349-54. PubMed ID: 20510019
[TBL] [Abstract][Full Text] [Related]
15. Cancer-testis specific gene OIP5: a downstream gene of E2F1 that promotes tumorigenesis and metastasis in glioblastoma by stabilizing E2F1 signaling.
He J; Zhao Y; Zhao E; Wang X; Dong Z; Chen Y; Yang L; Cui H
Neuro Oncol; 2018 Aug; 20(9):1173-1184. PubMed ID: 29547938
[TBL] [Abstract][Full Text] [Related]
16. CBX3 promotes glioma U87 cell proliferation and predicts an unfavorable prognosis.
Zhao SP; Wang F; Yang M; Wang XY; Jin CL; Ji QK; Li S; Zhao XL
J Neurooncol; 2019 Oct; 145(1):35-48. PubMed ID: 31502042
[TBL] [Abstract][Full Text] [Related]
17. Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axis.
Tang JH; Yang L; Chen JX; Li QR; Zhu LR; Xu QF; Huang GH; Zhang ZX; Xiang Y; Du L; Zhou Z; Lv SQ
Cancer Commun (Lond); 2019 Dec; 39(1):81. PubMed ID: 31796105
[TBL] [Abstract][Full Text] [Related]
18. Histone acetyltransferase inhibitor II induces apoptosis in glioma cell lines via the p53 signaling pathway.
Xu LX; Li ZH; Tao YF; Li RH; Fang F; Zhao H; Li G; Li YH; Wang J; Feng X; Pan J
J Exp Clin Cancer Res; 2014 Dec; 33(1):108. PubMed ID: 25523932
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Opa interacting protein 5 as a new biomarker and therapeutic target for oral cancer.
Zhu M; Takano A; Tsevegjav B; Yoshitake Y; Shinohara M; Daigo Y
Int J Oncol; 2022 Mar; 60(3):. PubMed ID: 35103287
[TBL] [Abstract][Full Text] [Related]
20. Possible involvement of Opa-interacting protein 5 in adipose proliferation and obesity.
Inoue K; Maeda N; Mori T; Sekimoto R; Tsushima Y; Matsuda K; Yamaoka M; Suganami T; Nishizawa H; Ogawa Y; Funahashi T; Shimomura I
PLoS One; 2014; 9(2):e87661. PubMed ID: 24516558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
